Lamivudine, an important drug in aids treatment

Journal of Sulfur Chemistry

Volumn 29, Issue 5, 2008, Pages 559-571

  Vasconcelos, T R A ^a   Ferreira, M L ^b   Goncalves R S B ^b   Da Silva, E T ^b   De Souza, M V N ^b  

^a FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

AIDS; Lamivudine; Sulfur

Indexed keywords

BIOMOLECULES;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AIDS; AIDS TREATMENTS; ANTIRETROVIRALS; HEPATITIS B; LAMIVUDINE; NUCLEOSIDE ANALOGS; SIDE EFFECT; SYNTHETIC STRATEGIES; THERAPY PROGRAM;

SULFUR;

EID: 54049147320     PISSN: 17415993     EISSN: 17416000     Source Type: Journal    
DOI: 10.1080/17415990802183876     Document Type: Article

References (30)

1. Sirois, S.; Sing, T.; Chou, K. Curr. Protein Pept. Sci. 2005, 6, 413-422.
2. Wang, T.; Gong, Y.; Shi, P. Front. Biotechnol. Pharm. 2000, 1, 282-304.
3. UNESCO. 2006 report on the global AIDS epidemic, 2006.
4. www.fda.gov/oashi/aids/virals.html (accessed Nov 28, 2007)
5. Brun, E.M.; García, M.G.; Puchades, R.; Maquieira, A. J. Immunol. Methods 2004, 295, 21-35.
6. Curtin, D.; Beare, M.H.; McCallum, F.M. Soil Biol. Biochem. 2007, 39, 2547-2554.
7. Cundari, S.; Dalpozzo, R.; Nino, A.; Procopio, A.; Sindona, G. Tetrahedron 1999, 55, 10155-10162.
8. De Souza, M.V.N. J. Sulfur Chem. 2005, 26, 429-449.
9. Chen, S. Curr. Med. Chem. 2002, 9, 899-912.
10. Taylor, C.L.; Wilkins, E.G. Future Virol. 2007, 2 (1), 11-21.
11. Bergmann, W.; Burke, D.C. J. Org. Chem. 1955, 20, 1501-1507.
12. Horwitz, J.P.; Chua, J.; Noel, M. J. Org. Chem. 1964, 29, 2076-2078.
13. Dionne, G. McGill J. Med. 1999, 5, 60-69.
14. Coates, J.A.V.; Mutton, I.M.; Penn, C.R.; Storer, R.; Williamson, C. WO 91/17159, 1991.
15. Ohta, Y.; Shinkai, I. Bioorg. Med. Chem. 1997, 5, 639-640.
16. Anglada, M.P.; Felipe, A.; Casado, F.J. Trends Pharmacol. Sci. 1998, 19, 424-430.
17. Choi, W.; Schinazi, R.; Wilson, L.J.; Yeola, S.; Liotta, D.C. J. Am. Chem. Soc. 1991, 113, 9377-9379.
18. Jeong, L.S.; Schinazi, R.F.; Beach, J.W.; Shanmu, K.; Choi, B.G.; Comer, F.I.; Alves, A.J.; Chu, C.H. J. Org. Chem. 1991, 56, 6503-6505.
19. Jeong, L.S.; Schinazi, R.F.; Beach, J.W.; Kim, H.O.; Shanmu, K.; Nampalli, S.; Chun, M.W.; Chung, W.-K.; Choi, B.G.; Chu, C.K. J. Med. Chem. 1993, 36, 2627-2638.
20. Jeong, L.S.; Alves, A.J.; Carrigan, S.W.; Kim, H.O.; Beach, J.W.; Chu, C.K. Tetrahedron Lett. 1992, 33, 595-598.
21. Jeong, L.S.; Beach, J.W.; Kim, H.O.; Alves, A.J.; Pohl, D.; Chang, C.-N.; Doong, S.-L.; Schinazi, R.F.; Cheng, Y.-C.; Chu, K. J. Org. Chem. 1992, 57, 2217-2219.
22. Jin, H.; Siddiqui, M.A.; Evans, C.A.; Allan, H.L.; Mansour, T.S. J. Org. Chem. 1995, 60, 2621-2623.
23. Cousins, R.P.C.; Mahmoudian, M.; Youds, P.M. Tetrahedron Asymmetry, 1995, 6, 393-396.
24. Milton, J.; Brand, S.; Jones, M.F.; Rayner, C.M. Tetrahedron Lett. 1995, 36, 6961-6964.
25. Milton, J.; Brand, S.; Jones, M.F.; Rayner, C.M. Tetrahedron Asymmetry, 1995, 6, 1903-1906.
26. Linderman, R.J.; Tennyson, S.D.; Shultz, D.A. Tetrahedron Lett. 1994, 46, 6437-6440.
27. Goodyear, M.D.; Hill, M.L.; West, J.P.; Whitehead, A.J. Tetrahedron Lett. 2005, 46, 9535-9538.
28. Jian, Z.; Gregory, C.E.; Wang, H.; Laurene, H.; James, B.J.A.; Robert, B.M. J. Clin. Pharm. 2007, 47, 877-881.
29. World Health Organisation. Fixed-Dose Combinations for HIV/AIDS, Tuberculosis and Malaria, WHO: Geneva, 2003.
30. Food and Drug Administration. Guidance for Industry: Fixed Dose Combinations, Co-Packaged Drug Products and Single-Entity Versions of Previously Approved Antiretrovirals for the Treatment of HIV, FDA/CDER: Rockville, 2006.